Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential.
about
Listeriolysin O as cytotoxic component of an immunotoxinThe role of the activated macrophage in clearing Listeria monocytogenes infectionChannel-forming bacterial toxins in biosensing and macromolecule deliveryEnhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccineDesign and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.Bioreducible polycations in nucleic acid delivery: past, present, and future trends.Polyplex gene delivery modulated by redox potential gradients.Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and NucleusProgrammed drug delivery: nanosystems for tumor targeting.Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugateBioresponsive polymers for the delivery of therapeutic nucleic acids.Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells.History of Polymeric Gene Delivery Systems.Cholesterol transport from liposomal delivery vehicles.Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
P2860
Q30319103-0A4A38AD-0351-4CD9-BC68-D5B3D8F4BC93Q33776753-1E71C1BD-0111-496A-B868-06220FC5CB0AQ34101821-1A2C1199-1978-4366-80A6-5C0E8D3312DAQ35052945-FAB2F54D-C7D8-48AE-8BF2-E08E6787F078Q35057551-B2D0983C-74A9-4D2F-95A6-3ED5EE5D8D4CQ35539055-308827F9-449F-4419-93FD-541131C30DC9Q36627789-17B564BB-096D-4A42-8A9D-497021C926E8Q36689670-AE8BFE00-08AB-4397-BA69-6F4D45C86288Q36810261-28D3FF98-1AFF-4ACA-B851-3CE0AC6162BDQ37217780-18ABABE3-BE72-403A-BBB0-954AE80EEA31Q37763677-7A8A4C39-A861-45AE-BE1E-B20B69C98B7FQ37981217-8AA1730A-204A-4246-9770-6E875E4EE1C9Q38161927-6F1BC240-215C-4780-B18C-8B491FA02F4CQ38597840-2BDE63A1-F3D1-422B-9E54-A2E0F82BC069Q38759514-08F75F7C-3777-46CF-9AF7-0D9544ABEEAFQ42265489-CFCADD3C-4A8E-4504-8337-FC2F4189E8C9Q58728426-31870A87-BC5C-4609-B171-DC29A77C2DD7
P2860
Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Enhanced cytosolic delivery of ...... g cellular reducing potential.
@en
type
label
Enhanced cytosolic delivery of ...... g cellular reducing potential.
@en
prefLabel
Enhanced cytosolic delivery of ...... g cellular reducing potential.
@en
P2093
P2860
P356
P1433
P1476
Enhanced cytosolic delivery of ...... g cellular reducing potential.
@en
P2093
P2860
P2888
P356
10.1038/SJ.GT.3301859
P577
2003-01-01T00:00:00Z
P5875
P6179
1041324716